Editorial [Hot Topic: Cyclooxygenases and Cyclooxygenase Inhibitors in Neurological and Psychiatric Diseases (Executive Editor: Luisa Minghetti) ]
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1400-1400
Author(s):
Luisa Minghetti
Cyclooxygenase-1 and -2 in the Different Stages of Alzheimers Disease Pathology
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1419-1427
Author(s):
J. J.M. Hoozemans, J. M. Rozemuller, E. S. van Haastert, R. Veerhuis and P. Eikelenboom
Cyclooxygenase-2 in Synaptic Signaling
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1443-1451
Author(s):
Hongwei Yang and Chu Chen
Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1512-1524
Author(s):
Rodrigo A. Cunha, Sergi Ferre, Jean-Marie Vaugeois and Jiang-Fan Chen
Stem Cell Therapies for the Lysosomal Storage Diseases – the Quintessential Neurodegenerative Diseases
Journal:
Current Stem Cell Research & Therapy
Volume:
3
Page:
88-98
Author(s):
Philip Hitchins Schwartz and David Joseph Brick
Analysis of NCL Proteins from an Evolutionary Standpoint
Journal:
Current Genomics
Volume:
9
Page:
115-136
Author(s):
Neda E. Muzaffar and David A. Pearce
Part-Time α-Secretases: The Functional Biology of ADAM 9, 10 and 17
Journal:
Current Alzheimer Research
Volume:
5
Page:
187-201
Author(s):
Miriam Deuss, Karina Reiss and Dieter Hartmann
Hormone Replacement Therapy and Stroke
Journal:
Current Vascular Pharmacology
Volume:
6
Page:
112-123
Author(s):
Antonia M.R. Billeci, Maurizio Paciaroni, Valeria Caso and Giancarlo Agnelli
Molecular Targets of Rheumatoid Arthritis
Journal:
Inflammation & Allergy - Drug Targets (Discontinued)
Volume:
7
Page:
53-66
Author(s):
Hiroshi Okamoto, Daisuke Hoshi, Akiko Kiire, Hisashi Yamanaka and Naoyuki Kamatani
Imaging Amyloid Pathology in the Living Brain
Journal:
Current Medical Imaging
Volume:
4
Page:
56-62
Author(s):
Nobuyuki Okamura, Shozo Furumoto, Hiroyuki Arai, Ren Iwata, Kazuhiko Yanai and Yukitsuka Kudo